This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_OVARY_MUCINO_EXALLC for full statistics.
Mucinous and mucinous cystic tumor
C3_OVARY_MUCINO
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
151 |
4. Check minimum number of eventsNone |
151 |
5. Include endpointsNone |
151 |
6. Filter based on genotype QC (FinnGen only) |
151 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Mucinous and mucinous cystic tumor
based on the number of shared cases.
Similar with more cases:
- Mucinous and mucinous cystic tumor, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of ovary
- Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)
- malignant neoplasm of female genital organs
- malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 151 | 151 | - |
| Unadjusted period prevalence (%) | 0.05 | 0.05 | - |
| Median age at first event (years) | 51.58 | 51.58 | - |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 142
- Matched controls
- 1420
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C56.72
ICD-10 Finland
Mucinous epithelial carcinoma of the ovary
+∞
155.0
119
*
8470/3-C56.9
ICD-O-3
Mucinous cystadenocarcinoma, NOS, of ovary
+∞
114.6
94
*
8480/3-C56.9
ICD-O-3
Mucinous adenocarcinoma of ovary
+∞
53.6
48
*
JAL30
NOMESCO Finland
Omentectomy
95.2
46.9
50
8
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
36.0
38.8
50
21
LAF16
NOMESCO Finland
Excision of uterus, adnexes and lymph nodes for treatment of ovarian cancer
238.7
36.6
36
*
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
39.1
33.5
42
15
128
Kela drug reimbursment
Cancers of female genital organs
28.7
29.5
40
19
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
22.3
29.1
43
27
JEA00
NOMESCO Finland
Appendectomy
14.4
28.5
51
53
LCD00
NOMESCO Finland
Hysterectomy
13.8
26.9
49
52
C56
ICD-10 Finland
Malignant neoplasm of ovary
90.4
21.4
23
*
D39.11
ICD-10 Finland
Epithelial tumor of uncertain nature in the ovary
217.5
19.0
19
*
LX1XE
NOMESCO Finland
Other gynecological ultrasound examination
14.9
17.9
30
25
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
48.9
17.8
21
5
121
Kela drug reimbursment
Severe hypofunction of sexual glands
18.4
17.0
26
17
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
34.8
16.7
21
7
JAL00
NOMESCO Finland
Biopsy of peritoneum
51.1
15.5
18
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
4.0
13.5
84
380
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
27.3
12.8
17
7
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.8
12.5
27
37
XLD00
NOMESCO Finland
Sytologyspecimen from mouth of uterus
4.4
11.9
49
151
A04AA01
ATC
ondansetron; systemic, rectal
7.2
11.7
29
49
B01AB10
ATC
tinzaparin; parenteral
7.3
11.1
27
44
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
9.7
10.5
21
25
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
18.4
10.1
15
9
TLE20
NOMESCO Finland
Transvaginal puncture of cul-de-sac
59.1
9.8
11
*
B01AB05
ATC
enoxaparin; parenteral
3.2
9.5
68
318
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
9.5
9
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.2
8.9
28
64
1830A
ICD-9 Finland
Malignant neoplasm of ovary and other uterine adnexa, Ovary
53.4
8.8
10
*
C567
ICD-10 Finland
NA
53.4
8.8
10
*
D39.19
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary with unspecified histology
53.4
8.8
10
*
Z31.5
ICD-10 Finland
Genetic counselling
6.5
8.6
22
39
C56.79
ICD-10 Finland
Other epithelial carcinoma of the ovary
95.5
8.5
9
*
D27.91
ICD-10 Finland
Benign epithelial tumor of the ovary (ovary)
14.2
8.1
13
10
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
3.7
8.0
37
123
D39.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Ovary
84.3
7.5
8
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
42.1
6.8
8
*
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
73.0
6.5
7
*
H02AB02
ATC
dexamethasone; systemic
3.7
6.4
28
88
JN4BD
NOMESCO Finland
Extensive body CT
4.0
6.3
25
72
18301
ICD-8 Finland
Malignant neoplasm of ovary, Fallopian tube and broad ligament, Ovary
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(4281824)
24
23
12.22
22.37
1.2
1.1
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
45
143
4.06
12.81
1.8
4.2
ug/l
17.6
10.0
0.38
37
115
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
9
16
5.91
3.72
1.0
1.3
—
—
—
0
0
(4035726)
25
120
2.30
3.21
1.3
1.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
11
5.63
2.57
3.2
2.3
—
—
—
0
0
(40768793) Breast Pathology biopsy report
0
65
0.00
2.49
0.0
1.2
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
5
8
6.42
2.39
3.4
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
17
4.26
2.39
1.1
1.7
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
126
1373
0.50
2.31
11.8
10.0
u/l
23.4
23.5
0.03
118
1322
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
6
13
4.76
2.29
1.2
1.8
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
118
1306
0.56
2.12
14.6
12.8
mg/l
27.9
19.5
1.77
99
1014
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
112
1255
0.58
2.07
6.3
5.4
mu/l
1.8
1.8
0.02
102
1152
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
15
4.12
2.06
1.2
1.7
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
16
292
0.49
1.94
1.8
1.4
g/l
1.9
2.4
0.78
11
169
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
5
12
4.27
1.84
1.2
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
114
1257
0.62
1.64
3.9
4.5
mmol/l
5.9
5.8
0.31
97
1162
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
5
14
3.65
1.63
2.0
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
21
123
1.82
1.61
13.6
5.3
mmol/l
1.7
1.5
0.06
16
105
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
119
1296
0.61
1.55
4.3
5.0
mmol/l
2.9
2.8
0.52
105
1200
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
12
58
2.16
1.54
20.2
6.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
5
15
3.41
1.53
1.0
1.1
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
86
999
0.68
1.53
4.0
4.1
mm/h
14.2
11.8
0.72
80
905
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
6
139
0.41
1.48
2.2
1.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
13
66
2.06
1.48
3.4
3.7
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
108
1197
0.66
1.46
4.7
5.5
mmol/mol
39.4
39.3
0.05
98
1113
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
117
1274
0.64
1.42
3.7
4.4
mmol/l
4.9
4.8
0.28
104
1188
(3032080) INR in Blood by Coagulation assay
60
472
1.45
1.38
5.4
7.4
inr
1.2
1.2
0.26
18
158
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
17
3.00
1.37
1.2
1.6
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
0
37
0.00
1.36
0.0
2.7
—
0.2
—
0
10
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
112
1225
0.67
1.29
15.3
12.4
ml/min/173m2
83.0
80.7
0.57
92
1004
(3052851) Hemolysis interference index of Serum or Plasma
8
36
2.29
1.26
3.3
2.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
16
257
0.58
1.26
1.5
1.5
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
22
325
0.62
1.24
1.2
1.2
u/ml
0.8
2.2
—
7
93
(3006315) Basophils [#/volume] in Blood
52
646
0.70
1.24
8.2
4.9
e9/l
0.0
0.0
0.18
42
556
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
8
151
0.50
1.22
2.0
2.0
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
70
825
0.72
1.20
2.5
3.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
26
2.36
1.20
1.8
1.5
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
52
643
0.71
1.19
8.2
4.8
e9/l
0.6
0.5
0.44
42
555
(40761511) CBC panel - Blood by Automated count
128
1358
0.62
1.17
12.7
11.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
20
2.55
1.16
1.8
1.5
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
54
660
0.72
1.14
7.9
4.8
e9/l
1.8
2.1
0.69
47
586
(3000991) Gas panel - Venous blood
13
74
1.83
1.10
19.2
6.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
13
74
1.83
1.10
3.1
2.5
kpa
3.9
3.8
0.03
13
74
(3023103) Potassium [Moles/volume] in Serum or Plasma
125
1330
0.65
1.10
18.4
14.5
mmol/l
3.9
3.9
0.37
120
1290
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
33
2.17
1.07
1.3
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
49
390
1.38
1.02
1.9
2.0
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
7
35
2.05
1.01
6.9
4.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
25
344
0.67
1.01
17.8
7.0
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
9
49
1.89
1.00
1.3
2.4
%
1.0
1.1
—
9
49
(3004789) Transferrin [Mass/volume] in Serum or Plasma
10
171
0.56
0.99
2.3
2.0
g/l
2.1
2.4
—
10
158
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
0
29
0.00
0.99
0.0
1.4
—
—
—
0
0
(3020564) Creatinine [Moles/volume] in Serum or Plasma
129
1359
0.65
0.97
18.1
15.1
umol/l
66.8
69.0
0.82
129
1359
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
19
126
1.58
0.97
1.7
1.7
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
118
1262
0.70
0.95
3.7
4.4
mmol/l
1.6
1.6
0.16
103
1170
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
27
2.27
0.94
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
27
2.27
0.94
1.2
1.2
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
19
127
1.57
0.94
1.6
1.8
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
112
1206
0.72
0.91
3.4
3.9
mmol/l
1.3
1.2
0.37
97
1111
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
6
29
2.11
0.90
1.8
1.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
6
112
0.52
0.87
1.2
1.1
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
26
190
1.45
0.86
4.0
3.0
e6/l
3.2
4.1
0.21
14
98
(3013115) Eosinophils [#/volume] in Blood
57
669
0.76
0.84
8.0
5.3
e9/l
0.2
0.2
0.20
47
588
(3006504) Eosinophils/100 leukocytes in Blood
51
605
0.76
0.81
8.0
4.9
%
2.4
2.7
0.62
44
556
(3005033) Fetal Nuchal fold Thickness US
0
25
0.00
0.80
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
25
0.00
0.80
0.0
1.3
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
26
0.00
0.79
0.0
1.5
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
0
26
0.00
0.79
0.0
2.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
14
91
1.59
0.78
4.3
3.1
kpa
6.3
6.0
0.57
14
91
(3013512) EKG study
32
403
0.74
0.77
3.3
3.5
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
52
609
0.78
0.73
8.1
5.2
%
8.6
8.2
0.63
45
563
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
63
717
0.79
0.69
7.5
5.4
umol/l
9.3
9.8
0.48
58
675
(3018010) Neutrophils/100 leukocytes in Blood
53
615
0.79
0.68
7.7
4.9
%
59.3
56.7
0.61
47
568
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
69
605
1.26
0.68
3.8
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
24
310
0.73
0.67
3.9
4.5
—
—
—
0
0
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
10
62
1.66
0.67
20.9
5.9
%
1.5
1.3
—
10
62
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
10
62
1.66
0.67
21.6
5.9
%
0.7
0.7
—
10
62
(3049717) Cytology report of Urine Cyto stain
7
44
1.62
0.66
5.0
2.8
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
54
622
0.79
0.64
7.9
5.1
%
26.4
28.8
0.76
48
569
(3022096) Basophils/100 leukocytes in Blood
50
581
0.79
0.64
8.3
4.9
%
0.6
0.7
0.73
43
531
(3048929) Epstein Barr virus Ab [Presence] in Serum
5
29
1.75
0.64
1.2
1.2
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
9
141
0.62
0.64
2.0
1.5
%
1.3
1.3
—
9
123
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
16
219
0.70
0.63
5.1
3.7
ng/l
180.5
85.6
0.23
16
167
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
8
49
1.67
0.63
3.4
3.1
%
45.1
40.8
—
8
49
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
0
21
0.00
0.60
0.0
1.0
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
67
592
1.24
0.60
7.8
4.5
mmol/l
1.2
1.2
0.59
58
534
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
64
1.60
0.60
1.6
1.5
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
110
1166
0.79
0.58
17.9
13.8
%
39.6
39.5
0.05
72
852
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
8
121
0.64
0.57
1.5
1.4
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
15
203
0.71
0.56
1.3
1.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
9
59
1.56
0.56
23.4
6.2
%
93.7
93.8
—
9
59
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
73
656
1.22
0.55
8.2
5.0
mmol/l
1.2
1.2
0.63
59
546
(3005719) IgG [Mass/volume] in Serum or Plasma
6
99
0.59
0.54
5.7
2.5
g/l
7.6
9.8
—
6
93
(40761536) Microorganisms panel - Urine sediment
16
118
1.40
0.53
4.2
3.5
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
24
190
1.31
0.52
1.8
1.8
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
7
45
1.58
0.49
1.9
1.5
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
7
46
1.55
0.49
1.3
1.3
g/l
0.3
0.2
—
7
46
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
7
47
1.51
0.48
1.3
1.3
g/l
1.3
1.2
—
7
47
(3000330) Specific gravity of Urine by Test strip
10
68
1.50
0.48
5.5
3.4
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
40
460
0.82
0.45
7.5
3.8
e6/l
408.4
63.9
0.62
27
317
(3015377) Calcium [Moles/volume] in Serum or Plasma
41
468
0.83
0.42
4.9
3.1
mmol/l
2.4
2.4
0.70
32
409
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(4268621)
0
15
0.00
0.41
0.0
1.8
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
25
206
1.26
0.41
3.6
2.7
e6/l
1.0
1.2
0.17
13
113
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
16
0.00
0.41
0.0
1.5
—
4.9
—
0
7
(40768795) Lymph node Pathology biopsy report
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
0
16
0.00
0.41
0.0
1.2
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.1
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
35
1.44
0.39
1.0
1.1
—
1.2
—
0
7
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
3.2
2.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
34
293
1.21
0.38
1.9
2.0
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
14
178
0.76
0.37
2.0
1.9
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
47
523
0.85
0.36
2.0
1.9
pmol/l
97.4
100.9
0.18
20
240
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
6
42
1.45
0.36
2.2
2.1
g/l
2.4
1.7
—
6
35
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
11
82
1.37
0.35
1.4
1.5
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
30
346
0.83
0.34
3.1
3.2
ng/l
435.0
1205.0
2.70
25
294
(3033658) Prothrombin time (PT) actual/Normal
35
306
1.19
0.34
4.5
3.3
%
96.7
96.2
0.04
35
296
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
53
580
0.87
0.32
1.9
2.3
nmol/l
78.0
79.9
0.16
44
514
(3022948) Iron [Moles/volume] in Serum or Plasma
15
185
0.79
0.32
2.1
2.0
umol/l
12.2
12.8
0.09
15
171
(3044889) 12 lead EKG panel
84
890
0.87
0.32
3.9
3.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
47
518
0.87
0.31
4.9
3.9
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
79
839
0.88
0.30
3.2
2.9
u/l
48.7
39.8
0.40
68
784
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
7
55
1.29
0.30
1.1
1.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
14
173
0.79
0.30
1.3
1.2
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
8
108
0.73
0.30
1.3
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
34
300
1.17
0.30
4.3
3.4
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
85
897
0.88
0.29
6.0
4.8
—
239.2
—
0
18
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
98
1024
0.88
0.28
7.3
6.8
u/l
80.4
76.9
0.38
88
940
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
43
473
0.87
0.28
3.1
3.7
ng/l
19.6
34.0
0.88
29
320
(3007853) Bacteria identified in Skin by Aerobe culture
17
141
1.23
0.27
1.4
1.6
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
44
400
1.14
0.26
7.1
4.8
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
59
547
1.13
0.26
5.1
3.8
g/l
35.0
35.8
0.39
54
510
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
41
451
0.88
0.26
4.7
3.1
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
16
133
1.23
0.25
8.3
3.0
mmol/l
1.0
1.0
0.18
16
118
(3012544) pH of Venous blood
12
96
1.27
0.25
4.8
3.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
6
83
0.71
0.24
2.5
1.8
g/l
0.9
1.6
—
6
75
(3013826) Glucose [Moles/volume] in Serum or Plasma
77
729
1.11
0.24
8.2
3.9
mmol/l
6.5
6.5
0.03
70
669
(3022621) pH of Urine by Test strip
7
93
0.74
0.23
4.3
2.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
8
104
0.76
0.22
2.1
1.6
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
11
89
1.25
0.21
9.1
3.5
pmol/l
4.6
4.4
0.51
11
77
(4010399)
11
89
1.25
0.21
1.3
1.4
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
11
0.00
0.21
0.0
1.7
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.8
—
11.2
—
0
11
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
11
0.00
0.21
0.0
1.0
—
245.8
—
0
11
(4027681)
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
8.2
—
0.7
—
0
10
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
10
80
1.27
0.21
1.1
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
61
647
0.90
0.21
5.0
3.8
estimate
0.0
0.0
0.00
16
138
(3020717) Zinc [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.1
—
18.2
—
0
13
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
14
165
0.83
0.20
3.9
4.4
%
34.8
34.6
—
5
107
(3005570) Glucose [Moles/volume] in Urine
0
14
0.00
0.20
0.0
3.3
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
88
914
0.91
0.19
4.8
4.5
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
7
58
1.22
0.18
28.7
3.7
mmol/l
25.3
25.1
—
7
58
(3000494) Fungus identified in Specimen by Culture
14
163
0.84
0.18
1.9
1.3
—
—
—
0
0
(3015736) pH of Urine
47
502
0.91
0.18
4.4
3.6
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
43
461
0.91
0.18
5.4
3.1
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
24
266
0.88
0.17
1.3
1.3
iu/ml
59.7
35.4
—
7
100
(3041096) Erythrocytes [Presence] in Urine by Automated
36
389
0.90
0.17
4.6
3.4
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
12
101
1.20
0.17
1.8
2.4
ng/l
66.8
69.9
0.10
12
85
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
12
101
1.20
0.17
2.5
1.6
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
32
348
0.90
0.17
5.2
3.0
—
—
—
0
0
(3013650) Neutrophils [#/volume] in Blood by Automated count
73
762
0.92
0.17
12.7
8.6
e9/l
3.8
4.0
0.26
56
670
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
8
70
1.15
0.16
1.1
1.7
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
11
92
1.21
0.16
8.4
2.5
g/l
65.9
66.9
0.26
11
87
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
12
139
0.85
0.15
1.7
1.7
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
8
100
0.79
0.14
1.0
1.3
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
36
383
0.92
0.12
5.4
3.2
e6/l
65.6
58.5
0.05
25
293
(3037522) Nuclear Ab [Titer] in Serum
17
188
0.89
0.11
1.2
1.4
titre
256.0
610.2
—
5
55
(3019309) Folate [Moles/volume] in Red Blood Cells
23
249
0.91
0.11
1.8
1.7
nmol/l
1303.0
1170.4
0.16
11
187
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
320
0.92
0.11
1.3
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
18
164
1.11
0.10
1.1
1.5
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
6
54
1.12
0.09
2.5
2.4
mmol/l
26.4
25.2
—
6
54
(3018418) pH of Serum or Plasma
44
422
1.06
0.08
4.5
3.4
ph
7.4
7.4
—
6
81
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
106
1078
0.94
0.08
5.3
4.6
pmol/l
15.3
14.8
1.14
96
975
(3011397) Hemoglobin [Presence] in Urine by Test strip
26
276
0.93
0.08
5.1
3.8
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
37
353
1.06
0.08
1.4
1.4
—
—
—
0
0
(3019225) pH of Specimen
14
127
1.11
0.08
1.6
3.4
—
—
—
0
0
(3000492) Spirometry study
11
98
1.13
0.08
1.6
1.6
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
8
73
1.10
0.07
5.3
2.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
61
592
1.05
0.07
11.1
8.5
e9/l
0.0
0.0
0.42
50
491
(3030467) Casts [#/volume] in Urine by Automated count
34
356
0.94
0.07
5.1
3.0
e6/l
0.1
0.5
1.55
25
263
(3004716) Salmonella sp identified in Stool by Organism specific culture
7
82
0.85
0.07
2.3
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
56
577
0.95
0.07
1.9
2.1
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
13
119
1.10
0.06
9.5
4.1
u/l
324.6
249.9
0.33
13
112
(3012516) Albumin [Mass/volume] in Urine
35
337
1.05
0.05
3.2
2.9
mg/l
21.2
29.0
0.28
19
200
(3021601) Nitrite [Presence] in Urine by Test strip
64
654
0.96
0.05
7.1
5.2
estimate
0.0
0.0
0.00
15
138
(46235355) HIV 1 and 2 tests - Meaningful Use set
20
190
1.06
0.04
1.5
1.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
65
659
0.98
0.02
4.8
3.8
estimate
0.0
0.0
0.00
16
134
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
13
123
1.06
0.01
4.1
3.5
—
—
—
0
0
(3002256) Pathology report gross observation
17
169
1.01
0.00
1.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
36
359
1.00
0.00
2.9
3.7
mg/mmol
3.1
6.5
0.80
21
203
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
41
409
1.00
0.00
3.4
2.2
u/l
55.2
54.0
0.05
36
373
(1761868) Lipid panel - Serum or Plasma
46
463
0.99
0.00
3.0
2.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
35
348
1.01
0.00
4.3
4.2
estimate
0.0
0.0
0.00
14
140
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
27
268
1.01
0.00
1.2
1.3
u/ml
4.7
12.9
0.98
11
105
(3017143) Hepatitis C virus Ab [Presence] in Serum
12
122
0.98
0.00
1.2
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
5
57
0.87
0.00
1.8
1.8
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
10.7
—
0
6
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
5.0
—
0
8
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
24.4
—
0
5
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
8
0.00
0.00
0.0
5.0
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4198724)
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
0
6
0.00
0.00
0.0
3.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
9
0.00
0.00
0.0
1.2
—
2.0
—
0
9
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
3.2
—
121.0
—
0
5
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
6
66
0.91
0.00
1.8
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
15
150
1.00
0.00
4.5
6.4
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
0
5
0.00
0.00
0.0
1.0
—
153.4
—
0
5
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
36.9
—
0
6
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
2.0
—
115.2
—
0
6
(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
6.3
—
0
6
(3024263) Appearance of Synovial fluid
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
6
0.00
0.00
0.0
4.3
—
44.5
—
0
6
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
20.1
—
1190.9
—
0
7
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
33.2
—
0
6
(4211845)
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
9
99
0.90
0.00
3.0
3.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
111.3
—
0
6
(3010838) Calcium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
30.7
—
2619.4
—
0
7
(3000012) Reticulocyte production index
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
629.8
—
0
6
(3044927) Protein electrophoresis panel - Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3016724) Homocysteine [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.5
—
10.8
—
0
8
(4024509)
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
1.0
—
0
7
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
8
85
0.94
0.00
1.0
1.3
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_OVARY_MUCINO – Mucinous and mucinous cystic tumor
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).